- LINKS
-
About us
Click here for more information about this topic.
More information
-
- Bookmark this page
- gross
Top 10 Products
Our ten top-selling products in 2011
The future of medicine lies in individual approaches and in building bridges between prevention, diagnosis and therapy. Bayer HealthCare Pharmaceuticals meets this challenge with proven, successful products based on many decades of knowledge and experience.
| Product | Indication | Sales |
|---|---|---|
| Betaferon®/Betaseron® | multiple sclerosis | € 1,117 million |
| Kogenate® | hemophilia | € 1,075 million |
| YAZ®/ Yasmin®/ Yasminelle® |
hormonal contraceptive | € 1,070 million |
| Nexavar® | kidney and liver cancer | € 725 million |
| Adalat® | high blood pressure | € 640 million |
| Mirena® | hormonal intrauterine delivery system for contraception | € 581 million |
| Avalox®/Avelox® | respiratory tract infections | € 486 million |
| Aspirin® Cardio | prevention heart attack | € 404 million |
| Glucobay® | Diabetes | € 362 million |
| Levitra® | drug for treating erectile dysfunction | € 332 million |
Products are ranked by full year 2011 sales.
- Age-related macular degeneration (AMD)
- Breast cancer
- Central retinal vein occlusion (CRVO)
- Colorectal Cancer (CRC)
- Contraception
- Diabetes
- Diabetic macular edema (DME)
- Endometriosis
- Erectile dysfunction
- Gastrointestinal stromal tumor (GIST)
- Gynecological therapy
- Heart attack
- Heartattack and stroke
- Hemophilia
- High blood pressure
- Infectious diseases
- Liver cancer
- Lung cancer
- Menopausal complaints
- Multiple sclerosis
- Peripheral arterial occlusive disease
- Premenstrual dysphoric disorder (PMDD)
- Prostate cancer
- Pulmonary arterial hypertension
- Renalcell carcinoma
- Stroke
- Testosterone deficiency
- Thrombosis
- Thyroid Cancer
Page tools
- B/W version
- A | A | A | Font size
